How should we regulate heritable human genome editing in Australia?
Field | Value | Language |
dc.contributor.author | Nicol, Dianne | |
dc.contributor.author | Rudge, Christopher | |
dc.contributor.author | Paxton, Rebecca | |
dc.contributor.author | Niemeyer, Simon | |
dc.date.accessioned | 2024-11-06T04:00:48Z | |
dc.date.available | 2024-11-06T04:00:48Z | |
dc.date.issued | 2022 | en_AU |
dc.identifier.uri | https://hdl.handle.net/2123/33237 | |
dc.description.abstract | Heritable human genome editing is a form of modification of the human genome that will be inherited by progeny of the person whose DNA has been edited. Editing human genomes in ways that are heritable is currently prohibited in many countries throughout the world, including in Australia. This section starts with an examination of the historical backdrop to Australia's current laws relating to heritable human genome editing, with particular focus on how technological advances and community responses have shaped our legislative environment for innovative artificial reproductive technologies. The section then examines how community responses to current developments in heritable human genome editing might shape future law reform. The aim is to provide a foundation for examining how the future regulatory environment for heritable human genome editing in Australia might be shaped in ways that are responsive both to technological developments and to contemporary ethical norms and social values. | en_AU |
dc.language.iso | en | en_AU |
dc.publisher | Thomson Reuters | en_AU |
dc.relation.ispartof | Journal of Law and Medicine | en_AU |
dc.rights | Copyright All Rights Reserved | en_AU |
dc.subject | heritable human genome editing | en_AU |
dc.subject | governance of genome editing | en_AU |
dc.subject | embryo research | en_AU |
dc.subject | mitochondrial donation | en_AU |
dc.subject | citizens’ jury | en_AU |
dc.title | How should we regulate heritable human genome editing in Australia? | en_AU |
dc.type | Article | en_AU |
dc.subject.asrc | ANZSRC FoR code::48 LAW AND LEGAL STUDIES::4804 Law in context::480412 Medical and health law | en_AU |
dc.subject.asrc | ANZSRC FoR code::48 LAW AND LEGAL STUDIES::4804 Law in context::480408 Law, science and technology | en_AU |
dc.type.pubtype | Publisher's version | en_AU |
dc.rights.other | This article was published by Thomson Reuters in the Journal of Law and Medicine and should be cited as Nicol, D., Rudge, C., Paxton, R., & Niemeyer, S. (2022). How should we regulate heritable human genome editing in Australia? Journal of Law and Medicine, 29(2), 322–336. For all subscription inquiries please phone, from Australia: 1300 304 195, from Overseas: +61 2 8587 7980 or online at legal.thomsonreuters.com.au/search. The official PDF version of this article can also be purchased separately from Thomson Reuters at http://sites.thomsonreuters.com.au/journals/subscribe-or-purchase. This publication is copyright. Other than for the purposes of and subject to the conditions prescribed under the Copyright Act 1968 (Cth), no part of it may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission. Enquiries should be addressed to Thomson Reuters (Professional) Australia Limited. PO Box 3502, Rozelle NSW 2039. legal.thomsonreuters.com.au | en_AU |
usyd.faculty | SeS faculties schools::The University of Sydney Law School | en_AU |
usyd.citation.volume | 29 | en_AU |
usyd.citation.issue | 2 | en_AU |
usyd.citation.spage | 322 | en_AU |
usyd.citation.epage | 336 | en_AU |
workflow.metadata.only | No | en_AU |
Associated file/s
Associated collections